New hope for advanced prostate cancer: drug combo trial launches
NCT ID NCT07590934
First seen May 17, 2026 · Last updated May 18, 2026 · Updated 1 time
Summary
This study tests two experimental drugs (AZD9574 and AZD2265) in people with metastatic prostate cancer that has spread. The goal is to check safety and see if the combination can shrink tumors or lower PSA levels. About 152 participants will join this early-phase trial at multiple centers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
Roma, 00168, Italy
-
Research Site
Seoul, 03080, South Korea
-
Research Site
Seoul, 03722, South Korea
-
Research Site
Seoul, 06351, South Korea
-
Research Site
Seoul, 06591, South Korea
-
Research Site
Seoul, 5505, South Korea
-
Research Site
Barcelona, 08028, Spain
-
Research Site
L'Hospitalet de Llobregat, 08908, Spain
-
Research Site
Madrid, 28031, Spain
-
Research Site
Madrid, 28041, Spain
-
Research Site
Pamplona, 31008, Spain
-
Research Site
Fulham, SW3 6JJ, United Kingdom
-
Research Site
Guildford, CU2 7XX, United Kingdom
-
Research Site
London, WC1E 6DB, United Kingdom
-
Research Site
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
Oxford, OX3 7LE, United Kingdom
-
Research Site
Encino, California, 91436, United States
-
Research Site
South Pasadena, California, 91030, United States
-
Research Site
Miami, Florida, 33165, United States
-
Research Site
Tampa, Florida, 33612, United States
-
Research Site
Minneapolis, Minnesota, 55455, United States
-
Research Site
Omaha, Nebraska, 68130, United States
-
Research Site
New York, New York, 10065, United States
-
Research Site
Portland, Oregon, 97239, United States
-
Research Site
Houston, Texas, 77030, United States
-
Research Site
North Adelaide, 5000, Australia
-
Research Site
Essen, 45147, Germany
-
Research Site
Rostock, 18057, Germany
-
Research Site
Tübingen, 72076, Germany
-
Research Site
Bergamo, 24127, Italy
-
Research Site
Meldola, 47014, Italy
-
Research Site
Milan, 20133, Italy
-
Research Site
Milan, 20141, Italy
Conditions
Explore the condition pages connected to this study.